ANIP ANI Pharmaceuticals | $82.07 -2.0% | 7/10/2026 | | Reiterated Rating | $124.00 | Buy | 00.00% | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 7/10/2026 |
INSM Insmed | $115.61 -2.2% | 7/10/2026 | | Reiterated Rating | $207.00 | Buy | 00.00% | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 7/10/2026 |
LGN LGN | $73.66 -0.4% | 7/10/2026 | | Boost Price Target | $106.00 ➝ $115.00 | Buy | 00.00% | View details for Guggenheim rating of LGN (NASDAQ:LGN) on 7/10/2026 |
ABBV AbbVie | $248.00 -0.8% | 7/9/2026 | | Boost Price Target | $249.00 ➝ $261.00 | Buy | 00.00% | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 7/9/2026 |
RVMD Revolution Medicines | $186.88 -2.2% | 7/9/2026 | | Boost Price Target | $205.00 ➝ $235.00 | Buy | 00.00% | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 7/9/2026 |
VERA Vera Therapeutics | $42.00 -1.1% | 7/8/2026 | | Boost Price Target | $56.00 ➝ $76.00 | Buy | 00.00% | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 7/8/2026 |
WAT Waters | $377.35 +0.1% | 7/8/2026 | | Reiterated Rating | $440.00 | Buy | 00.00% | View details for Guggenheim rating of Waters (NYSE:WAT) on 7/8/2026 |
SN SharkNinja | $152.62 +2.6% | 7/6/2026 | | Boost Price Target | $145.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 7/6/2026 |
EWTX Edgewise Therapeutics | $45.41 -6.1% | 7/6/2026 | | Boost Price Target | $41.00 ➝ $51.00 | Buy | 00.00% | View details for Guggenheim rating of Edgewise Therapeutics (NASDAQ:EWTX) on 7/6/2026 |
PBLS Parabilis Medicines | $30.57 +0.7% | 7/6/2026 | | Initiated Coverage | $40.00 | Buy | 00.00% | View details for Guggenheim rating of Parabilis Medicines (NASDAQ:PBLS) on 7/6/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
PBLS Parabilis Medicines | $30.57 +0.7% | 7/6/2026 | | Initiated Coverage | $40.00 | Buy | 00.00% | View details for Guggenheim rating of Parabilis Medicines (NASDAQ:PBLS) on 7/6/2026 |
CNK Cinemark | $29.01 -2.0% | 7/2/2026 | | Set Price Target | $37.00 | | 00.00% | View details for Guggenheim rating of Cinemark (NYSE:CNK) on 7/2/2026 |
KR Kroger | $60.58 +1.2% | 7/2/2026 | | Reiterated Rating | $71.00 | Buy | 00.00% | View details for Guggenheim rating of Kroger (NYSE:KR) on 7/2/2026 |
SEPN Septerna | $35.93 -5.0% | 7/1/2026 | | Lower Price Target | $52.00 ➝ $45.00 | Buy | 00.00% | View details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 7/1/2026 |
CHKP Check Point Software Technologies | $131.70 -4.7% | 7/1/2026 | | Upgrade | $188.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 7/1/2026 |
NOW ServiceNow | $107.81 -0.9% | 7/1/2026 | | Upgrade | $125.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 7/1/2026 |
CRM Salesforce | $163.34 +0.5% | 7/1/2026 | | Upgrade | $228.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 7/1/2026 |
NKE NIKE | $44.39 +3.8% | 7/1/2026 | | Reiterated Rating | $74.00 ➝ $60.00 | Buy | 00.00% | View details for Guggenheim rating of NIKE (NYSE:NKE) on 7/1/2026 |
PRGS Progress Software | $37.86 -1.7% | 7/1/2026 | | Reiterated Rating | $83.00 | Buy | 00.00% | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 7/1/2026 |
GLUE Monte Rosa Therapeutics | $23.04 -6.0% | 6/30/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 6/30/2026 |
GLUE Monte Rosa Therapeutics | $23.04 -6.0% | 6/30/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 6/30/2026 |
ABVX Abivax | $139.90 -0.6% | 6/30/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Abivax (NASDAQ:ABVX) on 6/30/2026 |
TSLA Tesla | $407.76 +0.3% | 6/29/2026 | | Initiated Coverage | | Sell ➝ Neutral | 00.00% | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 6/29/2026 |
WGS GeneDx | $65.64 -5.4% | 6/29/2026 | | Reiterated Rating | $70.00 ➝ $74.00 | Buy | 00.00% | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 6/29/2026 |
VCYT Veracyte | $56.97 -3.9% | 6/29/2026 | | Boost Price Target | $45.00 ➝ $65.00 | Buy | 00.00% | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 6/29/2026 |
TWST Twist Bioscience | $90.64 -3.2% | 6/29/2026 | | Boost Price Target | $60.00 ➝ $107.00 | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 6/29/2026 |
NTRA Natera | $269.95 -4.2% | 6/29/2026 | | Boost Price Target | $270.00 ➝ $290.00 | Buy | 00.00% | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 6/29/2026 |
ILMN Illumina | $190.20 -1.8% | 6/29/2026 | | Boost Price Target | $180.00 ➝ $200.00 | Buy | 00.00% | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/29/2026 |
GH Guardant Health | $160.05 -2.5% | 6/29/2026 | | Boost Price Target | $135.00 ➝ $160.00 | Buy | 00.00% | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 6/29/2026 |
BRKR Bruker | $60.06 -0.9% | 6/29/2026 | | Boost Price Target | $50.00 ➝ $70.00 | Buy | 00.00% | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 6/29/2026 |
BLLN Billiontoone | $126.77 -0.9% | 6/29/2026 | | Initiated Coverage | $120.00 ➝ $125.00 | Buy | 00.00% | View details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 6/29/2026 |
ADPT Adaptive Biotechnologies | $21.06 -3.4% | 6/29/2026 | | Boost Price Target | $21.00 ➝ $22.00 | Buy | 00.00% | View details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 6/29/2026 |
HD Home Depot | $343.45 +1.4% | 6/29/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Home Depot (NYSE:HD) on 6/29/2026 |
PFGC Performance Food Group | $113.31 +1.1% | 6/29/2026 | | Boost Price Target | $115.00 ➝ $125.00 | Buy | 00.00% | View details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 6/29/2026 |
JNJ Johnson & Johnson | $257.17 -0.7% | 6/26/2026 | | Boost Price Target | $266.00 ➝ $270.00 | Buy | 00.00% | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 6/26/2026 |
TVTX Travere Therapeutics | $56.59 -3.2% | 6/25/2026 | | Boost Price Target | $56.00 ➝ $65.00 | Buy | 00.00% | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 6/25/2026 |
OKLO Oklo | $48.84 -0.9% | 6/25/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Oklo (NYSE:OKLO) on 6/25/2026 |
AMLX Amylyx Pharmaceuticals | $17.77 -3.3% | 6/25/2026 | | Boost Price Target | $30.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 6/25/2026 |
DKNG DraftKings | $26.48 +0.7% | 6/24/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 6/24/2026 |
DRI Darden Restaurants | $204.21 +1.1% | 6/24/2026 | | Boost Price Target | $230.00 ➝ $235.00 | Buy | 00.00% | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 6/24/2026 |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
EYPT Eyepoint Pharmaceuticals | $14.72 -0.8% | 6/24/2026 | | Reiterated Rating | $68.00 | Buy | 00.00% | View details for Guggenheim rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 6/24/2026 |
APGE Apogee Therapeutics | $133.65 +0.1% | 6/23/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 6/23/2026 |
DASH DoorDash | $191.82 -0.3% | 6/23/2026 | | Reiterated Rating | $255.00 | Buy | 00.00% | View details for Guggenheim rating of DoorDash (NASDAQ:DASH) on 6/23/2026 |
PRIM Primoris Services | $86.73 -3.0% | 6/23/2026 | | Reiterated Rating | $162.00 | Buy | 00.00% | View details for Guggenheim rating of Primoris Services (NYSE:PRIM) on 6/23/2026 |
KR Kroger | $60.58 +1.2% | 6/22/2026 | | Set Price Target | $78.00 ➝ $71.00 | Buy | 00.00% | View details for Guggenheim rating of Kroger (NYSE:KR) on 6/22/2026 |
ACN Accenture | $135.19 -2.8% | 6/22/2026 | | Lower Price Target | $225.00 ➝ $185.00 | Buy | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 6/22/2026 |
TENX Tenax Therapeutics | $17.55 -4.2% | 6/22/2026 | | Reiterated Rating | $34.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 6/22/2026 |
ACN Accenture | $135.19 -2.8% | 6/22/2026 | | Lower Price Target | $225.00 ➝ $185.00 | Buy | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 6/22/2026 |
KR Kroger | $60.58 +1.2% | 6/22/2026 | | Reiterated Rating | $78.00 ➝ $71.00 | Buy | 00.00% | View details for Guggenheim rating of Kroger (NYSE:KR) on 6/22/2026 |
QCOM Qualcomm | $189.16 -1.0% | 6/22/2026 | | Set Price Target | $200.00 | | 00.00% | View details for Guggenheim rating of Qualcomm (NASDAQ:QCOM) on 6/22/2026 |
SIRI Sirius XM | $30.42 -0.9% | 6/17/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 6/17/2026 |
VIA Via Transportation | $17.98 -1.8% | 6/17/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Via Transportation (NYSE:VIA) on 6/17/2026 |
SPRB Spruce Biosciences | $50.07 -3.2% | 6/16/2026 | | Initiated Coverage | $123.00 | Buy | 00.00% | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 6/16/2026 |
SPRB Spruce Biosciences | $50.07 -3.2% | 6/16/2026 | | Initiated Coverage | $123.00 | Buy | 00.00% | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 6/16/2026 |
PINS Pinterest | $22.53 -0.7% | 6/15/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 6/15/2026 |
LTH Life Time Group | $41.85 +0.4% | 6/15/2026 | | Boost Price Target | $36.00 ➝ $41.00 | Buy | 00.00% | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 6/15/2026 |
ABSI Absci | $10.60 -7.6% | 6/15/2026 | | Boost Price Target | $10.00 ➝ $15.00 | Buy | 00.00% | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 6/15/2026 |
RZLT Rezolute | $4.75 -7.4% | 6/15/2026 | | Boost Price Target | $6.00 ➝ $11.00 | Buy | 00.00% | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 6/15/2026 |
TGT Target | $134.94 +2.0% | 6/12/2026 | | Boost Price Target | $140.00 ➝ $145.00 | Buy | 00.00% | View details for Guggenheim rating of Target (NYSE:TGT) on 6/12/2026 |
STUB STUB | $11.13 -3.4% | 6/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 6/12/2026 |
RH RH | $165.20 -1.9% | 6/12/2026 | | Reiterated Rating | $200.00 | Buy | 00.00% | View details for Guggenheim rating of RH (NYSE:RH) on 6/12/2026 |
SEPN Septerna | $35.93 -5.0% | 6/11/2026 | | Initiated Coverage | $52.00 | Buy | 00.00% | View details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 6/11/2026 |
ACN Accenture | $135.19 -2.8% | 6/11/2026 | | Lower Price Target | $250.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 6/11/2026 |
ORCL Oracle | $140.69 -2.4% | 6/11/2026 | | Reiterated Rating | $400.00 | Buy | 00.00% | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 6/11/2026 |
SEPN Septerna | $35.93 -5.0% | 6/11/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 6/11/2026 |
DNTH Dianthus Therapeutics | $97.60 -2.4% | 6/10/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 6/10/2026 |
ZVRA Zevra Therapeutics | $13.35 -4.2% | 6/10/2026 | | Boost Price Target | $25.00 ➝ $29.00 | Buy | 00.00% | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 6/10/2026 |
NUVL Nuvalent | $123.90 +0.1% | 6/10/2026 | | Downgrade | $151.00 ➝ $124.00 | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 6/10/2026 |
NET Cloudflare | $268.46 -2.7% | 6/10/2026 | | Reiterated Rating | $140.00 | Sell | 00.00% | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 6/10/2026 |
LYFT Lyft | $15.61 -0.8% | 6/10/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Lyft (NASDAQ:LYFT) on 6/10/2026 |
PASG Passage Bio | $4.57 -3.0% | 6/10/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Passage Bio (NASDAQ:PASG) on 6/10/2026 |
BNTC Benitec Biopharma | $13.42 -0.4% | 6/10/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 6/10/2026 |
ZS Zscaler | $139.27 -5.3% | 6/10/2026 | | Reiterated Rating | $214.00 | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 6/10/2026 |
UBER Uber Technologies | $74.56 +0.3% | 6/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 6/9/2026 |
ROKU Roku | $140.69 +0.3% | 6/9/2026 | | Boost Price Target | $140.00 ➝ $145.00 | Buy | 00.00% | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 6/9/2026 |
TRDA Entrada Therapeutics | $6.92 -6.5% | 6/8/2026 | | Lower Price Target | $20.00 ➝ $17.00 | Buy | 00.00% | View details for Guggenheim rating of Entrada Therapeutics (NASDAQ:TRDA) on 6/8/2026 |
FIVE Five Below | $189.39 +2.8% | 6/8/2026 | | Lower Price Target | $260.00 ➝ $250.00 | Buy | 00.00% | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 6/8/2026 |
CLYM Climb Bio | $14.00 +1.3% | 6/8/2026 | | Initiated Coverage | $35.00 | Buy | 00.00% | View details for Guggenheim rating of Climb Bio (NASDAQ:CLYM) on 6/8/2026 |
CLYM Climb Bio | $14.00 +1.3% | 6/8/2026 | | Initiated Coverage | $35.00 | Buy | 00.00% | View details for Guggenheim rating of Climb Bio (NASDAQ:CLYM) on 6/8/2026 |
FRVO Fervo Energy | $27.13 -0.8% | 6/8/2026 | | Upgrade | $48.00 | Strong-Buy | 00.00% | View details for Guggenheim rating of Fervo Energy (NASDAQ:FRVO) on 6/8/2026 |
FRVO Fervo Energy | $27.13 -0.8% | 6/7/2026 | | Initiated Coverage | $48.00 | Buy | 00.00% | View details for Guggenheim rating of Fervo Energy (NASDAQ:FRVO) on 6/7/2026 |
ORCL Oracle | $140.69 -2.4% | 6/5/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 6/5/2026 |
RBRK Rubrik | $84.23 -5.1% | 6/5/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 6/5/2026 |
TSCO Tractor Supply | $30.43 +1.0% | 6/5/2026 | | Reiterated Rating | $60.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 6/5/2026 |
IRD Opus Genetics | $3.92 -2.5% | 6/4/2026 | | Initiated Coverage | $16.00 | Buy | 00.00% | View details for Guggenheim rating of Opus Genetics (NASDAQ:IRD) on 6/4/2026 |
IRD Opus Genetics | $3.92 -2.5% | 6/4/2026 | | Initiated Coverage | $16.00 | Buy | 00.00% | View details for Guggenheim rating of Opus Genetics (NASDAQ:IRD) on 6/4/2026 |
CELC Celcuity | $107.58 -5.2% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 6/3/2026 |
GTLB GitLab | $32.42 -4.3% | 6/3/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 6/3/2026 |
DG Dollar General | $118.91 +2.7% | 6/3/2026 | | Lower Price Target | $160.00 ➝ $140.00 | Buy | 00.00% | View details for Guggenheim rating of Dollar General (NYSE:DG) on 6/3/2026 |
YSWY Yesway | $20.38 -0.1% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 6/3/2026 |
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions. See the 5 stocks to avoid |
MSGS Madison Square Garden | $381.85 -1.4% | 6/2/2026 | | Boost Price Target | $422.00 ➝ $470.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 6/2/2026 |
JBIO Jade Biosciences | $20.95 -6.8% | 6/2/2026 | | Reiterated Rating | $47.00 | Buy | 00.00% | View details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 6/2/2026 |
DELL Dell Technologies | $435.14 -3.3% | 6/1/2026 | | Upgrade | | Buy | 00.00% | View details for Guggenheim rating of Dell Technologies (NYSE:DELL) on 6/1/2026 |
COST Costco Wholesale | $916.25 +0.4% | 6/1/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 6/1/2026 |
ZS Zscaler | $139.27 -5.3% | 6/1/2026 | | Upgrade | $214.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 6/1/2026 |
ILMN Illumina | $190.20 -1.8% | 6/1/2026 | | Boost Price Target | $170.00 ➝ $180.00 | Buy | 00.00% | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/1/2026 |
OCS Oculis | $13.63 -0.5% | 6/1/2026 | | Lower Price Target | $75.00 ➝ $45.00 | Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 6/1/2026 |
DLTR Dollar Tree | $124.91 +3.3% | 5/29/2026 | | Boost Price Target | $130.00 ➝ $135.00 | Buy | 00.00% | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 5/29/2026 |
BBY Best Buy | $82.97 +3.7% | 5/29/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 5/29/2026 |
MDB MongoDB | $342.08 -5.7% | 5/29/2026 | | Reiterated Rating | $475.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 5/29/2026 |